Why the Obesity Drug Revolution Is a Work in Progress
5 days ago · A new class of weight-loss drugs known as GLP-1s are proving to be game changers for people with obesity. They’re also minting billions for pharmaceutical companies, especially the companies ...
FDA declares the shortage of obesity drug ... - Health News Florida
Dec 28, 2024 · The drug Zepbound might not have the same name recognition as Ozempic, but it's another in the class to treat obesity and Type 2 diabetes. And like Ozempic and Wegovy, Zepbound has been in short supply because of high demand. The Food and Drug Administration declared it resolved last week. NPR pharmaceuticals correspondent Sydney Lupkin joins us.
Biden proposes weight loss drug coverage requirements for ... - NBC News
Nov 26, 2024 · The Biden administration is proposing to reinterpret the law barring coverage by classifying obesity drugs as treatment for a "chronic disease," rather than as weight loss medications.
New Obesity Drug MariTide Helps Patients Lose Up to 20% of …
Nov 26, 2024 · The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by...
Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro...
How Anti-Obesity Drugs are Redefining Pharma and Wellness
Dec 20, 2024 · For more audio journalism and storytelling, download New York Times ... Two of the leading experts on anti-obesity drugs say the drugs are heralding a new era in medicine and could soon be used to ...
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in...
F.D.A. Approves New Obesity Drug That Will Compete With …
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy.
FDA approves Zepbound, a new obesity drug that will take on …
Nov 8, 2023 · An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy.